Abbvie Inc (ABBV) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Abbvie Inc   (NYSE: ABBV)
 

Abbvie Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Abbvie Inc 's inventory turnover ratio sequentially decreased to 3.4 in the third quarter 2026, unsurprisingly, as the Abbvie Inc markets continue to deteriorate, and ABBV's faces growing challenges to bring down its inventories. Abbvie Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 107 days, from 100 days, in the Jun 30 2026 quarter.

Within Healthcare sector 111 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1063, from total ranking in the second quarter 2026 at 1222.

ABBV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Abbvie Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABBV Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 7.43 % 3.37 % 11.56 % 18.42 % 10.97 %
Y / Y Cost of Sales Growth -19.21 % -1.27 % 5.4 % 3.55 % 25.93 %
Inventory Turnover Ratio (TTM) 3.4 3.66 3.7 3.76 3.88
ABBV's Total Ranking # 1063 # 1222 # 1050 # 1067 # 1041
Average inventory processing period 107 100 99 97 94
Seq. Inventory Growth 3.47 % 1.54 % 1.98 % 0.26 % -0.44 %
Seq. Cost of Sales Growth -0.14 % 1.73 % -7.34 % -14.18 % 22.04 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 25
Healthcare Sector # 112
Overall Market # 1063

Inventory Turnover Ratio Statistics
High Average Low
6.71 4.16 2.08
(Sep. 30, 2013)   (Sep. 30, 2012)



ABBV Company Profile >> Back to ABBV Efficiency Comparisons >> Compare ABBV Inventory Turnover Ratio to its Competitors

Financial Statements
Abbvie Inc 's Inventories $ 5,305 Millions Visit ABBV's Balance sheet
Abbvie Inc 's Cost of Revenues TTM $ 17,346 Millions Visit ABBV's Income Statement
What are ABBV's Sales? Visit ABBV's Sales by Segment

Other Inventory Turnover Ratios
Abbvie Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ABBV's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ABBV's Competitors
Inventory Turnover Ratio for ABBV's Suppliers
Inventory Turnover Ratio for ABBV's Customers

You may also want to know
ABBV's Sales Growth Rates ABBV's Pe Price to earnings ratio ABBV's Receivables Turnover Ratio ABBV's Stock Quote
ABBV's Net Income Growth Rates ABBV's Ps Price to Sales ratio ABBV's Sales per Employee ABBV's Asset Turnover Ratio
ABBV's Net Margin ABBV's Pb Price to Book ratio ABBV's Financial Strength Ratios ABBV's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions

Date modified: 2026-11-04T15:04:13+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.